Literature DB >> 67846

Autoimmune hyperlipidemia.

J L Beaumont, V Beaumont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 67846     DOI： 10.1016/0021-9150(77)90111-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  10 in total

Review 1.  Immunological aspects of atheroma: a review.

Authors:  R N Poston
Journal:  J R Soc Med       Date:  1979-09       Impact factor: 5.344

2.  Dyslipidemia in patients with systemic lupus erythematosus: Association with disease activity and B-type natriuretic peptide levels.

Authors:  Jiangshui Yuan; L I Li; Zhaoyan Wang; Weiqing Song; Zongliang Zhang
Journal:  Biomed Rep       Date:  2015-11-18

3.  Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia.

Authors:  A Corsini; P Roma; D Sommariva; R Fumagalli; A L Catapano
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

4.  Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies.

Authors:  Y Levy; M Aviram; G Spira; I Tatarsky; G J Brook; A Carter
Journal:  Postgrad Med J       Date:  1984-07       Impact factor: 2.401

5.  Monoclonal phosphorylcholine antibody binds to beta-lipoprotein from different animal species.

Authors:  U B Sørensen
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

Authors:  J L Witztum; U P Steinbrecher; Y A Kesaniemi; M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin.

Authors:  L L Kilgore; B W Patterson; D M Parenti; W R Fisher
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Atypical type III hyperlipoproteinemia in a patient with Ig A myelomatosis.

Authors:  G Feussner; E von Hodenberg; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-05-17

9.  Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa.

Authors:  M F Baudet; C Dachet; J L Beaumont
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

Review 10.  A Comprehensive Update on the Chylomicronemia Syndrome.

Authors:  Ronald B Goldberg; Alan Chait
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-23       Impact factor: 5.555
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.